GeranylacetateCAS# 105-87-3 |
- Nerylacetate
Catalog No.:BCN3802
CAS No.:141-12-8
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 105-87-3 | SDF | Download SDF |
PubChem ID | 1549026 | Appearance | Oil |
Formula | C12H20O2 | M.Wt | 196.3 |
Type of Compound | Monoterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [(2E)-3,7-dimethylocta-2,6-dienyl] acetate | ||
SMILES | CC(=CCCC(=CCOC(=O)C)C)C | ||
Standard InChIKey | HIGQPQRQIQDZMP-DHZHZOJOSA-N | ||
Standard InChI | InChI=1S/C12H20O2/c1-10(2)6-5-7-11(3)8-9-14-12(4)13/h6,8H,5,7,9H2,1-4H3/b11-8+ | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Geranyl acetate is widely used in the fragrance and cosmetic industries, and thus has great economic value. |
Geranylacetate Dilution Calculator
Geranylacetate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.0942 mL | 25.4712 mL | 50.9424 mL | 101.8849 mL | 127.3561 mL |
5 mM | 1.0188 mL | 5.0942 mL | 10.1885 mL | 20.377 mL | 25.4712 mL |
10 mM | 0.5094 mL | 2.5471 mL | 5.0942 mL | 10.1885 mL | 12.7356 mL |
50 mM | 0.1019 mL | 0.5094 mL | 1.0188 mL | 2.0377 mL | 2.5471 mL |
100 mM | 0.0509 mL | 0.2547 mL | 0.5094 mL | 1.0188 mL | 1.2736 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Daclatasvir
Catalog No.:BCN9991
CAS No.:1009119-64-5
- Phloroglucinol aldehyde triethylether
Catalog No.:BCN9990
CAS No.:59652-88-9
- 3-Octyl alcohol
Catalog No.:BCN9989
CAS No.:589-98-0
- trans-Aconitic acid
Catalog No.:BCN9988
CAS No.:4023-65-8
- Quercetin-3'-glucoside
Catalog No.:BCN9987
CAS No.:19254-30-9
- 1,3-Diphenyl-2-propen-1-one
Catalog No.:BCN9986
CAS No.:94-41-7
- 4'-Methoxyflavanone
Catalog No.:BCN9985
CAS No.:97005-76-0
- Farnesol
Catalog No.:BCN9984
CAS No.:4602-84-0
- (R,S)-Equol
Catalog No.:BCN9983
CAS No.:66036-38-2
- 4',6,7-Trimethoxyisoflavone
Catalog No.:BCN9982
CAS No.:798-61-8
- trans-Beta-Apo-8'-carotenal
Catalog No.:BCN9981
CAS No.:1107-26-2
- (-)-Verbenone
Catalog No.:BCN9980
CAS No.:1196-01-6
- Cytochalasin C
Catalog No.:BCN9993
CAS No.:22144-76-9
- 4-Hydroxyquinoline
Catalog No.:BCN9994
CAS No.:611-36-9
- 2',3,5,7-Tetrahydroxyflavone
Catalog No.:BCN9995
CAS No.:480-15-9
- 3,4-Dimethoxychalcone
Catalog No.:BCN9996
CAS No.:5416-71-7
- Oxyacanthine hydrochloride
Catalog No.:BCN9997
CAS No.:15352-74-6
- 7-Methoxyflavone
Catalog No.:BCN9998
CAS No.:22395-22-8
- trans-5-Hydroxyferulic acid
Catalog No.:BCN9999
CAS No.:110642-42-7
- 8-p-Coumaroylharpagide
Catalog No.:BCN0152
CAS No.:87686-74-6
- 2-(4-Methoxybenzal)acetophenone
Catalog No.:BCN0001
CAS No.:959-33-1
- N-Methylcolchicine
Catalog No.:BCN0002
CAS No.:7336-40-5
- Hydrocotarnine hydrobromide
Catalog No.:BCN0003
CAS No.:5985-00-2
- 8-Acetyl-7-methoxycoumarin
Catalog No.:BCN0004
CAS No.:89019-07-8
Chemical constituent and antimicrobial effect of essential oil from Myrtus communis leaves on microorganisms involved in persistent endodontic infection compared to two common endodontic irrigants: An in vitro study.[Pubmed:25298646]
J Conserv Dent. 2014 Sep;17(5):449-53.
INTRODUCTION: Persistent infections of human root canals play a fundamental role in the failure of endodontic treatment. The purpose of this study is to determine the chemical composition of Myrtus communis (M. communis) essential oil and to assess its antimicrobial activity against Enterococcus faecalis, Staphylococcus aureus and Candida albicans compared to that of sodium hypochlorite (NaOCl) and chlorhexidine (CHX). MATERIALS AND METHODS: Gas chromatography-mass spectrometry (GC-MS) was used to determine the chemical composition of essential oil from M. communis leaves. A micro-dilution susceptibility assay and disk diffusion methods were utilized to evaluate the antimicrobial activity [minimum inhibitory concentration (MIC) and minimum lethal dose concentration] of the tested solutions against selected microorganisms. RESULTS: GC-MS analyses revealed that M. communis contained 1, 8-Cineole (28.62%), alpha-Pinene (17.8%), Linalool (17.55%), and Geranylacetate (6.3%) as the major compounds and Geraniol (1.6%), alpha-Humulene (1.5%), eugenol (1.3%), isobutyl-isobutyrate (0.8%), and methyl chavicol (0.5%) as minor components. Chlorhexidine had the lowest MIC value among all medicaments tested. M. communis oil had less MIC values than NaOCl against both bacteria, but it had more MIC value against C. albicans. CONCLUSION: M. communis essential oil with the minimum inhibitory concentration in the range of 0.032-32 mug/mL was an effective antimicrobial agent against persistent endodontic microorganisms.
Efficient and selective microbial esterification with dry mycelium of Rhizopus oryzae.[Pubmed:11604169]
J Biotechnol. 2001 Dec 14;92(1):21-6.
The use of dry mycelium of Rhizopus oryzae as biocatalyst for ester production in organic solvent has been studied. Mycelia with notable carboxylesterase activity were produced when different Tweens (20, 40, 60 and 80) were employed as main carbon source for the growth. Dry mycelium of four strains of Rhizopus oryzae proved effective for efficiently catalysing the synthesis of different flavour esters (hexylacetate and butyrate, Geranylacetate and butyrate) starting from the corresponding alcohol and free acid, including acetic acid. The esterification of the racemic mixture of 2-octanol and butyric acid proceeded with high enantioselectivity (R-ester produced with enantiomeric excess > or =97%) when Rhizopus oryzae CBS 112.07 and Rhizopus oryzae CBS 260.28 were employed.